Charles River Prices Offering of 8,000,000 Shares.Business Editors and Health/Medical Writers BIOWIRE2K WILMINGTON, Mass.--(BW HealthWire)--July 20, 2001 Charles River Laboratories International, Inc. (NYSE NYSE See: New York Stock Exchange : CRL CRL - Carnegie Representation Language. Carnegie Group, Inc. Frame language derived from SRL. Written in Common LISP. Used in the product Knowledge Craft. ) announced today that it priced its public offering of 8,000,000 shares of common stock (excluding the underwriters' over-allotment option to purchase an additional 1,200,000 shares of common stock) at $29 per share. Of the 8,000,000 shares, 2,000,000 are being sold by the Company and 6,000,000 are being sold by selling stockholders. The joint lead managers for the offering are Credit Suisse First Boston Credit Suisse First Boston was originally the trading name of the Financière Crédit Suisse-First Boston, a London-based 50-50 investment banking joint venture formed in 1978 between the First Boston Corporation and Credit Suisse. and Lehman Brothers. A prospectus relating to the offering can be obtained upon request from the syndicate department of Credit Suisse First Boston, 11 Madison Avenue, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10010. (212-325-2000) Charles River Laboratories, based in Wilmington, Massachusetts, is a leading provider of critical research tools and integrated support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services that enable innovative and efficient drug discovery and development. The Company is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies. The Company also offers a broad and growing portfolio of biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. products and services that enable customers to reduce cost, increase speed, and enhance productivity and effectiveness in drug discovery and development. Charles River's customer base spans over 50 countries, and includes all of the major pharmaceutical and biotechnology companies, as well as many leading hospitals and academic institutions. The Company operates more than 76 facilities in 15 countries worldwide. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion